February 11, 2026

The Cincinnati Business Courier spoke with David Gius, MD, PhD, who was recently named the next director of the University of Cincinnati Cancer Center.

February 11, 2026

The University of Cincinnati’s Fabiano Nery, MD, PhD, has received a five-year, approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to launch a clinical trial testing two new nonpharmacological treatments for teens and young adults with depression.

February 10, 2026

Following a highly competitive national search, the University of Cincinnati Cancer Center has appointed David Gius, MD, PhD, as its next director.

February 9, 2026

Research from the University of Cincinnati College of Medicine, recently published in the journal Nature Communications, is revealing how immune cells in the adult brain regulate the generation of new neurons.

February 5, 2026

A new study by the University of Cincinnati uses a novel artificial intelligence to predict substance use disorder-defining behaviors with up to 83% accuracy.